New variant of Creutzfeldt Jakob disease.
Work on experimental pathology carried out for over 10 years indicates that the biological properties of the BSE agent, responsible for the new variant of Creutzfeldt-Jakob disease (vCJD), are particular. In contrast to the situation observed in the other
Dormont
D
D